COVID-19

Several workplace risk factors, including safety concerns going unaddressed, predicted suicidal thoughts.

Novavax announced the development of a protein-based monovalent XBB COVID-19 vaccine with the intention of it being manufactured and available for the fall vaccination campaign.

Investigators found that individuals who received metformin were approximately 40% less likely to develop long COVID than those who received a placebo.

Health care professionals can provide patients with tips on appropriate hand sanitizer use, as well as product recommendations.

In-person visits to receive oral therapy, outpatient infusions, and inpatient infusion for the treatment of hematologic neoplasms declined in the early months of the COVID-19 pandemic, while telemedicine use increased slightly in the same period but remained low overall.

Pharmacists who immunize must ensure their knowledge about routine vaccinations for adults and children is up-to-date by reviewing the changes to the immunization schedule each year.

It’s time for pharmacies to take a page out of the books of hospitals and tech companies by expanding and streamlining their use of contingent labor.

There may be more than 200 symptoms associated with long COVID-19.

It’s imperative to redefine the future of pharmacy to help ensure a robust pipeline of future pharmacists and create a culture that helps ensure pharmacists live their purpose and passion.

Investigators found thinner ventricular walls, disorganized and ruptured myocardial fiber, mild inflammatory infiltration, and mild epicardia or interstitial fibrosis in the hearts of mice infected with COVID-19.

Research shows receipt of medications for chronic conditions was relatively stable in the first 2 years of the pandemic from 2020 to 2021 across racial and ethnic groups.

Pharmacogenomic testing in combination with therapeutic drug monitoring can be a cost effective and efficient way to advance psychiatric drug therapy.

Decentralization has already been shown to streamline clinical trials, but it also has the potential to improve the broader health care ecosystem.

With so many radical developments in medicine and technology unfolding at once, the role and potential of the pharmacy as we know it is evolving at breakneck speed.

This marks the fourth drug, and first oral antiviral pill, approved by the FDA to treat adults with mild-to-moderate COVID-19.

EUA restriction for hospitalized patients was basis for lawsuit that advanced several arguments.

Reporting vaccination data to Immunization Information Systems databases can support public health surveillance activities.

The risk of long COVID-19 in females in the least deprived areas was comparable to the risk of males in the most deprived areas.

Many patients with post-COVID-19 condition reported perceived cognitive deficits early during their COVID-19 infection as well.

Federal legislation addresses variety of issues and seeks to build on gains made under the Affordable Care Act.

Study evaluates the effect of long-acting monoclonal antibodies tixagevimab and cilgavimab treating COVID-19 symptoms and viral shedding.

Investigators of the phase 2 study also found a comparable reactogenicity to the individual influenza and COVID-19 vaccines from Novavax or authorized vaccine comparators.

Study shows that the nervous system of individuals experiencing post-COVID-19 fatigue is underactive in 3 key areas.

Investigators found that providing parents with a hypothetical scenario outlining why they should immunize their children against COVID-19 was effective in improving vaccination rates.

The 2022-2023 COVID-19 season did not have a significant surge of COVID-19 like it did early on in the COVID-19 pandemic.